Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 2, Single-Arm Trial of BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-Paclitaxel in the First Line Setting of Advanced Pancreatic Adenocarcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07226856
Title field or adapter rule
{'original_value': 'Phase 2, Single-Arm Trial of BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-Paclitaxel in the First Line Setting of Advanced Pancreatic Adenocarcinoma', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:24.292772+00:00
Published At
2026-10-02T00:00:00+00:00
Record Updated At
2026-10-02
Source Retrieved At
2026-10-31T22:17:54.613222+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Metastatic Pancreatic Adenocarcinoma", "Recurrent Pancreatic Adenocarcinoma", "Stage IV Pancreatic Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-02", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07226856"
protocolSection.identificationModule.officialTitle
"Phase 2, Single-Arm Trial of BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-Paclitaxel in the First Line Setting of Advanced Pancreatic Adenocarcinoma"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Metastatic Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IV Pancreatic Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Treatment (BMS-986340, nivolumab, gemcitabine, nab-paclitaxel)'], 'description': 'Undergo tissue biopsy', 'name': 'Biopsy Procedure', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (BMS-986340, nivolumab, gemcitabine, nab-paclitaxel)'], 'description': 'Undergo urine and blood sample collection', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (BMS-986340, nivolumab, gemcitabine, nab-paclitaxel)'], 'description': 'Undergo CT', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (BMS-986340, nivolumab, gemcitabine, nab-paclitaxel)'], 'description': 'Given IV', 'name': 'Gemcitabine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (BMS-986340, nivolumab, gemcitabine, nab-paclitaxel)'], 'description': 'Given IV', 'name': 'Imzokitug', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (BMS-986340, nivolumab, gemcitabine, nab-paclitaxel)'], 'description': 'Undergo brain MRI', 'name': 'Magnetic Resonance Imaging', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (BMS-986340, nivolumab, gemcitabine, nab-paclitaxel)'], 'description': 'Given IV', 'name': 'Nab-paclitaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (BMS-986340, nivolumab, gemcitabine, nab-paclitaxel)'], 'description': 'Given IV', 'name': 'Nivolumab', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Gemcitabine (protocolSection.armsInterventionsModule.interventions[].name)
  • Nab-paclitaxel (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.